Skip to main content

Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01)

Main page content

Agency: NIH

Purpose: The purpose of this FOA is to support clinical studies that will fill gaps in the design of upcoming clinical trials in rare neurological or neuromuscular diseases by validating clinical outcome measures or biomarkers, or by characterizing cohorts of relevant patients...

Deadline: February 18, 2016; August 18, 2016; February 17, 2017; August 17, 2017; February 15, 2018; August 17, 2018, by 5:00 PM local time of applicant organization